Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2009
NCT02153879
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (3)

fenofibrate (fenoglide) (1 trial)

laropiprant (1 trial)

niacin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus, Type 2 (Phase 4)

Dyslipidemias (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 3